Your browser is no longer supported. Please, upgrade your browser.
Settings
ATRS Antares Pharma, Inc. daily Stock Chart
ATRS [NASD]
Antares Pharma, Inc.
Index- P/E- EPS (ttm)-0.13 Insider Own8.10% Shs Outstand160.35M Perf Week7.09%
Market Cap508.31M Forward P/E75.48 EPS next Y0.04 Insider Trans-13.92% Shs Float143.76M Perf Month17.84%
Income-19.90M PEG- EPS next Q-0.01 Inst Own39.40% Short Float4.43% Perf Quarter23.35%
Sales56.00M P/S9.08 EPS this Y31.70% Inst Trans4.83% Short Ratio7.03 Perf Half Y60.10%
Book/sh0.18 P/B17.61 EPS next Y150.00% ROA-21.80% Target Price3.97 Perf Year5.32%
Cash/sh0.18 P/C18.09 EPS next 5Y- ROE-48.50% 52W Range1.58 - 4.09 Perf YTD59.30%
Dividend- P/FCF- EPS past 5Y-0.70% ROI-28.20% 52W High-21.52% Beta0.20
Dividend %- Quick Ratio2.40 Sales past 5Y19.30% Gross Margin46.80% 52W Low103.16% ATR0.14
Employees111 Current Ratio2.90 Sales Q/Q5.80% Oper. Margin-29.40% RSI (14)66.96 Volatility5.95% 4.93%
OptionableYes Debt/Eq0.88 EPS Q/Q-29.50% Profit Margin-29.90% Rel Volume1.11 Prev Close3.17
ShortableYes LT Debt/Eq0.88 EarningsAug 07 BMO Payout- Avg Volume906.20K Price3.21
Recom1.40 SMA2013.56% SMA5016.13% SMA20037.92% Volume112,002 Change1.26%
Oct-23-17Reiterated H.C. Wainwright Buy $5 → $3.50
Jun-23-17Initiated H.C. Wainwright Buy $5
Apr-21-17Initiated Raymond James Strong Buy
May-28-15Initiated Jefferies Buy $5
May-18-15Initiated Piper Jaffray Overweight $3.50
Aug-08-13Reiterated Ladenburg Thalmann Buy $5 → $5.75
Jun-21-13Resumed Oppenheimer Outperform $6
Aug-15-18 08:25PM  Key FDA Decisions Could Power These 3 Biopharma Stocks SmarterAnalyst
Aug-14-18 08:00AM  Todays Research Reports on Stocks to Watch: Xenetic Biosciences and Antares Pharma ACCESSWIRE
Aug-13-18 04:35PM  Why Nielsen Holdings, Diebold Nixdorf, and Antares Pharma Jumped Today Motley Fool +10.54%
Aug-07-18 04:00PM  Robbins Arroyo LLP: Antares Pharma, Inc. (ATRS) Misled Shareholders According to a Class Action Business Wire
07:35AM  Antares Pharma: 2Q Earnings Snapshot Associated Press
07:00AM  Antares Pharma Reports Second Quarter 2018 Operating and Financial Results GlobeNewswire
06:30AM  Antares Pharma, Inc. to Host Earnings Call ACCESSWIRE
Aug-06-18 04:30PM  Antares Pharma Appoints Dr. James Tursi Executive Vice President, Head of Research & Development, Chief Medical Officer GlobeNewswire +11.15%
04:14PM  Here's Why Antares Pharma Jumped Today Motley Fool
10:20AM  Biotechnology Stocks Trending on New Developments 2018 ACCESSWIRE
08:51AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga
07:00AM  Antares Pharma Enters Into Development Agreement With Pfizer Inc. GlobeNewswire
Jul-31-18 07:00AM  Antares Pharma to Report Second Quarter 2018 Financial and Operating Results GlobeNewswire
Jul-26-18 08:20AM  Consolidated Research: 2018 Summary Expectations for South Jersey Industries, Cedar Realty Trust, Antares Pharma, Q2, Cree, and HCI Group Fundamental Analysis, Key Performance Indications GlobeNewswire
Jul-12-18 04:48AM  Edited Transcript of ATRS earnings conference call or presentation 8-May-18 12:30pm GMT Thomson Reuters StreetEvents
Jul-05-18 07:30AM  Complimentary Technical Snapshots on Akers Biosciences and Two More Medical Supplies Stocks ACCESSWIRE
Jun-25-18 11:58AM  Is Antares Pharma Incs (NASDAQ:ATRS) Balance Sheet A Threat To Its Future? Simply Wall St.
Jun-05-18 07:55AM  Akers Biosciences and Three Additional Stocks Under Scanner in the Medical Supplies Space ACCESSWIRE
May-30-18 07:00AM  Antares Pharma Announces Receipt of Third Installment From Sale of ZOMAJET Needle-Free Delivery System GlobeNewswire
May-29-18 07:00AM  Antares Pharma to Present at the Jefferies 2018 Healthcare Conference GlobeNewswire
May-18-18 07:10AM  Free Post Earnings Research Report: ResMeds Revenue Jumped 15%; Adjusted EPS Surged 30% ACCESSWIRE
May-14-18 10:55AM  ATRS: Makena Maturing Quickly, Providing 1Q:18 Boost Zacks Small Cap Research
May-08-18 08:33AM  Antares Pharma: 1Q Earnings Snapshot Associated Press
07:00AM  Antares Pharma Reports First Quarter 2018 Operating and Financial Results GlobeNewswire
May-02-18 07:00AM  Antares Pharma to Present at the Deutsche Bank Securities, Inc. 43rd Annual Health Care Conference GlobeNewswire
May-01-18 07:00AM  Antares Pharma to Report First Quarter 2018 Financial and Operating Results GlobeNewswire
Apr-05-18 07:00AM  Antares Pharma Provides XYOSTED Regulatory Update GlobeNewswire
Mar-27-18 11:00AM  ATRS: Xyosted Regulatory Update Zacks Small Cap Research
07:00AM  Antares Pharma Provides XYOSTED Regulatory Update GlobeNewswire
Mar-26-18 12:00PM  ATRS: Multiple New Launches Fire Up 2018 Zacks Small Cap Research
Mar-13-18 07:31PM  Edited Transcript of ATRS earnings conference call or presentation 13-Mar-18 12:30pm GMT Thomson Reuters StreetEvents
05:45PM  Antares Pharma Provides Update Regarding the Cowen and Company 38th Annual Healthcare Conference GlobeNewswire
07:23AM  Antares Pharma reports 4Q loss Associated Press
07:00AM  Antares Pharma Reports Fourth Quarter and Full Year 2017 Operating and Financial Results GlobeNewswire
06:45AM  Antares Pharma, Inc. to Host Earnings Call ACCESSWIRE
Mar-09-18 12:00PM  Antares Pharma to Present at the Cowen and Company 38th Annual Healthcare Conference GlobeNewswire
Mar-06-18 07:00AM  Antares Pharma to Report Fourth Quarter and Full Year 2017 Financial and Operating Results GlobeNewswire +5.24%
Mar-01-18 07:00AM  Antares Pharma Announces Receipt of Second Installment from Sale of Zomajet Needle-Free Delivery System GlobeNewswire
Feb-26-18 04:01PM  Antares Pharma to Present at the Raymond James & Associates 39th Annual Institutional Investors Conference GlobeNewswire
Feb-15-18 12:05PM  Why AMAG Pharmaceuticals, Inc. and Antares Pharma, Inc. Are Soaring Today Motley Fool +18.69%
08:25AM  Investor Expectations to Drive Momentum within Workday, The Medicines, Celldex Therapeutics, Lannett, Oclaro, and Antares Pharma Discovering Underlying Factors of Influence GlobeNewswire
07:13AM  Antares Pharma, Amag Pharma shares soar premarket after FDA approves auto injector MarketWatch
07:00AM  Antares Pharma Announces FDA Approval of Partners Product Utilizing Our QuickShot Auto Injector GlobeNewswire
Feb-14-18 06:21PM  Antares Pharma Announces FDA Approval of Partners Product Utilizing Our QuickShot Auto Injector GlobeNewswire
06:03PM  AMAG Pharmaceuticals Announces FDA Approval of Makena® (hydroxyprogesterone caproate injection) Subcutaneous Auto-Injector to Reduce the Risk of Preterm Birth in Certain At-Risk Women GlobeNewswire
Jan-16-18 07:00AM  Antares Pharma Provides XYOSTED Regulatory Update GlobeNewswire
Dec-22-17 11:36AM  ATRS INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Antares Pharma, Inc. and a Lead Plaintiff Deadline of December 22, 2017 ACCESSWIRE
10:08AM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Antares Pharma, Inc. (ATRS) and Lead Plaintiff Deadline - December 22, 2017 ACCESSWIRE
Dec-21-17 04:01PM  Antares Pharma Provides XYOSTED Regulatory Update GlobeNewswire
10:23AM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Antares Pharma, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 22, 2017 - ATRS ACCESSWIRE
Dec-20-17 09:55PM  ATRS Reminder Deadline Alert: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit against Antares Pharma, Inc. Business Wire
08:00AM  New Patent Issued to AMAG Pharmaceuticals Entitled "Methods of Reducing Risk of Preterm Birth" GlobeNewswire
02:20AM  ATRS UPCOMING DEADLINE: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Antares Pharma, Inc. and a Lead Plaintiff Deadline of December 22, 2017 ACCESSWIRE
Dec-19-17 04:31PM  Glancy Prongay & Murray Reminds Investors of the December 22, 2017 Deadline in the Class Action Lawsuit Against Antares Pharma, Inc. (ATRS) Business Wire
03:00AM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Antares Pharma, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 22, 2017 - ATRS ACCESSWIRE
Dec-18-17 05:25PM  Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Antares Pharma, Inc. (ATRS) and Encourages Investors to Contact the Firm Before December 22nd ACCESSWIRE
02:49PM  FINAL DEADLINE ALERT:  Brower Piven Reminds Investors Of Upcoming Deadline In Class Action Lawsuit And Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Antares Pharma, Inc. To Contact The Firm GlobeNewswire
02:11PM  DEADLINE APPROACHING: The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Antares Pharma, Inc. Shareholders and a Lead Plaintiff Deadline of December 22, 2017 (ATRS) ACCESSWIRE
10:07AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Antares Pharma, Inc. (ATRS) and Lead Plaintiff Deadline - December 22, 2017 ACCESSWIRE
Dec-14-17 03:02AM  ATRS EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Antares Pharma, Inc. and a Lead Plaintiff Deadline of December 22, 2017 ACCESSWIRE
Dec-13-17 04:40PM  IMPORTANT ANTARES PHARMA, INC. INVESTOR REMINDER LEAD PLAINTIFF DEADLINE RAPIDLY APPROACHING: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed on behalf of investors who purchased Antares Pharma, Inc. GlobeNewswire +5.38%
02:25PM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Antares Pharma, Inc. Shareholders of Commencement of a Class Action and a Lead Plaintiff Deadline of December 22, 2017 - ATRS ACCESSWIRE
Dec-12-17 05:14PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Antares Pharma, Inc. ATRS GlobeNewswire +5.08%
03:35PM  The Klein Law Firm Reminds Investors of Commencement of a Class Action Filed on Behalf of Antares Pharma, Inc. Shareholders and a Lead Plaintiff Deadline of December 22, 2017 (ATRS) ACCESSWIRE
Dec-11-17 06:34PM  Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Antares Pharma, Inc. Investors and Encourages Investors to Contact the Firm (ATRS) Business Wire
05:30PM  Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Antares Pharma, Inc. (ATRS) and Encourages Investors to Contact the Firm Business Wire
Dec-08-17 05:42PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Antares Pharma, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 22, 2017 - ATRS ACCESSWIRE
05:19PM  ANTARES LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Antares Pharma, Inc. To Contact The Firm Business Wire
Dec-07-17 02:38AM  ATRS EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Antares Pharma, Inc. and a Lead Plaintiff Deadline of December 22, 2017 ACCESSWIRE
Dec-06-17 05:25PM  ANTARES LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Antares Pharma, Inc. To Contact The Firm Business Wire
10:05AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Antares Pharma, Inc. (ATRS) and Lead Plaintiff Deadline: December 22, 2017 ACCESSWIRE
02:10AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Antares Pharma, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 22, 2017 - ATRS ACCESSWIRE
Dec-05-17 03:49PM  Glancy Prongay & Murray LLP Continues Investigation on Behalf of Antares Pharma, Inc. Investors (ATRS) Business Wire
02:30PM  The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Antares Pharma, Inc. Shareholders and a Lead Plaintiff Deadline of December 22, 2017 (ATRS) GlobeNewswire
12:00PM  Scott+Scott, Attorneys at Law, LLP Reminds Investors of December 22nd Lead Plaintiff Deadline in Securities Class Action Against Antares Pharma, Inc. (ATRS) Business Wire
Dec-04-17 06:37PM  ATRS INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Antares Pharma, Inc. Investors and Encourages Investors to Contact the Firm Business Wire -6.19%
Dec-01-17 08:30AM  Report: Exploring Fundamental Drivers Behind Lannett, Oclaro, Antares Pharma, Workday, The Medicines, and Celldex Therapeutics New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
02:00AM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Antares Pharma, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 22, 2017 - ATRS ACCESSWIRE
Nov-30-17 04:36PM  DEADLINE ALERT: Brower Piven Reminds Investors Of Upcoming Deadline In Class Action Lawsuit And Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Antares Pharma, Inc. To Contact The Firm Business Wire
01:26PM  ETFs with exposure to Antares Pharma, Inc. : November 30, 2017 Capital Cube
02:10AM  ATRS INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Antares Pharma, Inc. and a Lead Plaintiff Deadline of December 22, 2017 GlobeNewswire
Nov-29-17 10:24AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Antares Pharma, Inc. (ATRS) & Lead Plaintiff Deadline: December 22, 2017 ACCESSWIRE
09:00AM  ATRS INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of Antares Pharma, Inc. Investors Business Wire
02:00AM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Antares Pharma, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 22, 2017 ATRS GlobeNewswire
Nov-28-17 09:10PM  SHAREHOLDER ALERT: Pomerantz Law Reminds Shareholders with Losses on their Investment in Antares Pharma, Inc. of Class Action Lawsuit and Upcoming Deadline - ATRS ACCESSWIRE +6.25%
04:00PM  IMPORTANT Antares Pharma, Inc. Investor REMINDER: Wolf Haldenstein Adler Freeman & Herz LLP Reminds Investors that a Securities Class Action Lawsuit has been Filed on Behalf of Investors who Purchased Antares Pharma, Inc. ACCESSWIRE
02:51PM  ATRS LOSS NOTICE: Rosen Law Firm Reminds Antares Pharma, Inc. Investors of Important Deadline in Class Action Business Wire
12:56PM  Glancy Prongay & Murray LLP Commences Investigation on Behalf of Antares Pharma, Inc. Investors (ATRS) Business Wire
02:00AM  The Klein Law Firm Notifies Investors of a Class Action Filed on Behalf of Antares Pharma, Inc. Shareholders and a Lead Plaintiff Deadline of December 22, 2017 (ATRS) ACCESSWIRE
Nov-27-17 04:52PM  ANTARES LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Antares Pharma, Inc. To Contact The Firm ACCESSWIRE
02:30PM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Antares Pharma, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 22, 2017 - ATRS ACCESSWIRE
Nov-25-17 09:10PM  SHAREHOLDER ALERT: Pomerantz Law Reminds Shareholders with Losses on their Investment in Antares Pharma, Inc. of Class Action Lawsuit and Upcoming Deadline - ATRS ACCESSWIRE
Nov-23-17 09:08PM  SHAREHOLDER ALERT: Pomerantz Law Reminds Shareholders with Losses on their Investment in Antares Pharma, Inc. of Class Action Lawsuit and Upcoming Deadline - ATRS ACCESSWIRE
Nov-22-17 02:07PM  ATRS SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Antares Pharma, Inc. and a Lead Plaintiff Deadline of December 22, 2017 ACCESSWIRE
10:24AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Antares Pharma, Inc. (ATRS) & Lead Plaintiff Deadline - December 22, 2017 ACCESSWIRE
Nov-20-17 02:30PM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Antares Pharma, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 22, 2017 - ATRS ACCESSWIRE
Nov-18-17 09:06AM  SHAREHOLDER ALERT: Pomerantz Law Reminds Shareholders with Losses on their Investment in Antares Pharma, Inc. of Class Action Lawsuit and Upcoming Deadline - ATRS ACCESSWIRE
Nov-17-17 01:39PM  The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Antares Pharma, Inc. Shareholders and a Lead Plaintiff Deadline of December 22, 2017 Business Wire
09:01AM  Key Risk Factors Facing Antares Pharma in 2017 Market Realist
07:31AM  Taking a Deeper Look at Antares Pharmas Financials in 2017 Market Realist
Antares Pharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide. The company's injection products include OTREXUP that comprises of pre-filled methotrexate syringe and VIBEX self-injection system to enable rheumatoid arthritis (RA) and psoriasis patients to self-inject methotrexate at home; and Sumatriptan Injection USP for the acute treatment of migraine and cluster headache in adults. Its injection products also comprise Makena auto injectors to reduce the risk of preterm birth in women pregnant with a single baby; ZOMAJET and Twin-Jector II needle-free auto injectors to administer human growth hormone for patients with growth retardation; and VIBEX disposable pressure-assisted auto injectors. In addition, the company develops XYOSTED for the treatment of testosterone deficiency in adult males; VIBEX auto injectors for treating anaphylaxis; and disposable pen injectors for diabetes and osteoporosis. It has strategic alliances with Teva Pharmaceutical Industries, Ltd. and AMAG Pharmaceuticals, Inc., as well as a development agreement with Pfizer Inc. The company was founded in 1978 and is headquartered in Ewing, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GONELLA JACQUESDirectorAug 13Sale3.0949,507152,9779,985,848Aug 15 06:03 PM
GONELLA JACQUESDirectorAug 08Sale3.09250,493774,02310,035,355Aug 10 05:19 PM
GONELLA JACQUESDirectorJun 15Sale2.955651,66710,285,848Jun 20 05:51 PM
GONELLA JACQUESDirectorJun 12Sale2.77100,000277,00010,286,413Jun 13 05:24 PM
GONELLA JACQUESDirectorJun 11Sale2.69100,000269,00010,386,413Jun 13 05:24 PM
GONELLA JACQUESDirectorJun 06Sale2.7020,25954,69910,486,413Jun 07 07:16 PM
GONELLA JACQUESDirectorJun 05Sale2.55100,000255,00010,529,801Jun 05 05:54 PM
GONELLA JACQUESDirectorJun 05Sale2.7023,12962,44810,506,672Jun 07 07:16 PM
GONELLA JACQUESDirectorJun 04Sale2.65100,000265,00010,629,801Jun 05 05:54 PM
GONELLA JACQUESDirectorJun 01Sale2.7056,612152,85210,729,801Jun 05 05:54 PM
GONELLA JACQUESDirectorJun 01Sale2.6078,938205,23910,786,413Jun 01 05:52 PM
GONELLA JACQUESDirectorMay 30Sale2.55100,000255,00010,865,351Jun 01 05:52 PM
GONELLA JACQUESDirectorMay 23Sale2.51194,682489,54510,965,351May 24 05:47 PM
GONELLA JACQUESDirectorMay 22Sale2.535,31813,45511,160,033May 24 05:47 PM
GONELLA JACQUESDirectorMay 18Sale2.6021,06254,76111,165,351May 22 05:54 PM
GONELLA JACQUESDirectorMay 17Sale2.55100,000255,00011,186,413May 18 05:42 PM
GONELLA JACQUESDirectorMay 16Sale2.52100,000252,00011,286,413May 18 05:42 PM
GONELLA JACQUESDirectorMay 15Sale2.50100,000250,00011,386,413May 16 05:55 PM
GONELLA JACQUESDirectorMay 14Sale2.50100,000250,00011,486,413May 16 05:55 PM
APPLE ROBERT FPresident & CEOMay 11Option Exercise0.8582,50070,1251,334,971May 14 06:23 PM
GONELLA JACQUESDirectorMay 11Sale2.47100,000247,00011,586,413May 14 06:21 PM
GONELLA JACQUESDirectorMay 10Sale2.36100,000236,00011,686,413May 14 06:21 PM
GONELLA JACQUESDirectorMay 09Sale2.47300,000740,40011,786,413May 11 05:34 PM
GONELLA JACQUESDirectorMay 03Option Exercise0.8530,00025,50012,086,413May 07 05:35 PM
JACOB LEONARD SDirectorMar 29Option Exercise0.8532,40727,546239,892Apr 02 05:10 PM
APPLE ROBERT FPresident & CEODec 27Option Exercise1.2360,00073,800929,719Dec 29 05:33 PM
JACOB LEONARD SDirectorOct 09Option Exercise0.55218,600119,800407,485Oct 11 05:56 PM
JACOB LEONARD SDirectorOct 09Sale4.05230,000931,920207,485Oct 11 05:56 PM
GARRITY THOMAS JDirectorOct 03Option Exercise0.8530,00025,500190,213Oct 05 05:57 PM
GARRITY THOMAS JDirectorOct 03Sale3.5030,000105,000160,213Oct 05 05:57 PM